MedTrace Logo

Pea Protein and Postprandial Response (PEA)

NCT01215370 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2011-09-07

No results posted yet for this study

Summary

The main objective is to investigate the postprandial effect of arginine-rich protein (i.e. pea-protein) on metabolic control, inflammation and endothelial function after a high-fat meal in subjects with characteristics of the metabolic syndrome.

Conditions

  • Metabolic Syndrome

Interventions

OTHER

High-fat shake with Pea protein

Shake containing 95 gram of fat, additive 30 gram pea protein

OTHER

High-fat shake with Pea protein hydrolysate

Shake containing 95 gram of fat, additive 30 gram gluten protein hydrolysate

OTHER

High-fat shake - Control

Shake containing 95 gram of fat, no protein additive

OTHER

High-fat shake with Gluten protein

Shake containing 95 gram of fat, additive 30 gram gluten protein.

OTHER

High-fat shake with Gluten protein hydrolysate

Shake containing 95 gram of fat, additive 30 gram gluten gluten hydrolysate

Sponsors & Collaborators

  • Wageningen University

    lead OTHER

Principal Investigators

  • Marco Mensink, Dr · Department Human Nutrition, Wageningen University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01215370 on ClinicalTrials.gov